A recent study indicates that individuals who stop using blockbuster slimming jabs like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who end conventional lifestyle programs.
Published data in a leading medical journal shows that while overweight individuals often shed a large proportion of their total mass while undergoing treatment, the mass returns at an average rate of 0.8 kg per month once they quit.
"People purchasing these drugs need to be informed of the danger of rapid weight regain when the therapy concludes," warns researcher Dr. Susan Jebb.
Such speed of recovery implies a return to pre-treatment mass within about one and a half years.
Analyzing Treatments
The study, which looked at 37 of studies involving over 9,000 of patients, compared the effects of the injectable medications with conventional dieting.
Researchers point out that people who lose weight through diet and exercise generally experience a slower weight regain—perhaps 100 grams monthly—after stopping.
The Reason for the Fast Rebound
Nutrition scientists believe the mechanism of the jabs is key to understanding the accelerated rebound.
These medications copy a body's own chemical called GLP-1, which moderates feelings of fullness.
"Long-term administration of the hormone concentrations several times higher than normal could lead to the body to generate a reduced amount of its own natural hormone, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this medication results in appetite is no longer kept in check, making overeating far more likely."
A Lifelong Disease?
Medical guidelines recommend the injections for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians argue that, considering the likelihood of weight regain, the therapy might need to be long-term.
This opinion is supported by drug manufacturers, who state that the results "underscore the long-term nature of obesity," similar to managing diseases like high blood pressure.
User Experiences
People who have stopped the jabs report a sudden resurgence of hunger.
"It was like a trigger flipping and I was suddenly ravenous," described one woman.
This challenge is compounded if patients have not established sustainable lifestyle or habit modifications during therapy.
Significant Interest
Figures show that a significant number of adults in the UK have used these injections in the past year, with demand being substantial.
- Use is more common among women compared to men.
- The middle-aged age group shows the highest usage rates.
- Many obtain the medications through private healthcare rather than the NHS.
In conclusion, researchers caution that while the jabs are potent agents for weight loss, they are not a magic fix and long-term success hinges on combined lifestyle changes.
